The government has announced that certain NHS patients with coronavirus will soon be able to access Gilead’s remdesivir in a bid to speed up their recovery. The drug is currently being tested in clinical trials around the world, with early data showing it can shorten the time to recovery by about four days. The Early
According to new NHS research, people with type 1 diabetes are more likely to die of Covid-19 than those with type 2, thereby confirming that diabetes significantly increases coronavirus sufferers’ risk of dying. The study also mentions that almost a third of all deaths from coronavirus among people in hospital in England during the pandemic
NHS England has confirmed four new integrated care systems (ICS) in England, joining the 14 already in existence plus two devolved health systems in Greater Manchester and Surrey. The action leads to around half of England’s population now being served by such a system, including the whole of Yorkshire (with the confirmation of an ICS
Scottish government has recommended people cover their faces while in some enclosed public spaces, such as shops and public transport. First Minister Nicola Sturgeon said there could be “some benefit” in wearing a cloth face covering in places where social distancing was difficult. Although she said it was “not a substitute” for existing lockdown restrictions.
The coronavirus pandemic has caused global health authorities and agencies to introduce new measures as respective governments respond to growing outbreaks. That includes the NHS which announced today that it will increase its capabilities to test for the coronavirus, which causes the respiratory disease known as COVID-19. Currently, 1,500 tests can be carried out per
UK healthcare authorities have approved a free messaging app for use in hospitals, in a bid to prevent staff from sharing sensitive clinical information using consumer services such as WhatsApp. Hospify is the first general purpose messaging app to be given the stamp of approval by the organisations overseeing the NHS Apps Library. These include;
GSK has recruited China-based Clover Biopharmaceuticals, to help develop its protein-based coronavirus vaccine candidate (COVID-19 S-Trimer). Under the new agreement, GSK says it will provide Clover with its pandemic adjuvant system for further evaluation of S-Trimer in preclinical studies, in hopes that Clover could potentially rapidly scale-up and produce large-quantities of a new coronavirus vaccine.
The NHS has reported treating its first patient with Novartis’ Luxturna (voretigene neparvovec), which has been heralded as a “revolutionary” new gene therapy that can restore eyesight and is featured as part of its NHS Long Term Plan. The therapy is available for those born with an inherited retinal disorder (Leber’s Congenital Amaurosis, where patients
NHS England’s most senior nurse urges NHS organisations to boost the number of nursing apprenticeships they offer to local people, in order to help deliver the health service’s Long-Term Plan to improve patient care. England’s chief nursing officer, Ruth May, last week met 17 nurses in Cambridge who are among the first in the country
Survival rates from lung cancer by patients diagnosed in Scotland is among the lowest in Europe and lung cancer is the biggest killer of all cancers. During a recent meeting the Scottish Parliament in Edinburgh by the Cross-Party Group for Cancer it was agreed that there is a strong demand to consider a formal recommendation